Literature DB >> 34075367

Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees.

Anna Deal1,2, Sally E Hayward1,2, Mashal Huda1, Felicity Knights1, Alison F Crawshaw1, Jessica Carter1, Osama B Hassan1, Yasmin Farah1, Yusuf Ciftci3, May Rowland-Pomp1, Kieran Rustage1, Lucy Goldsmith1, Monika Hartmann3, Sandra Mounier-Jack2, Rachel Burns4, Anna Miller3, Fatima Wurie5, Ines Campos-Matos5, Azeem Majeed6, Sally Hargreaves1.   

Abstract

INTRODUCTION: Early evidence confirms lower COVID-19 vaccine uptake in established ethnic minority populations, yet there has been little focus on understanding vaccine hesitancy and barriers to vaccination in migrants. Growing populations of precarious migrants (including undocumented migrants, asylum seekers and refugees) in the UK and Europe are considered to be under-immunised groups and may be excluded from health systems, yet little is known about their views on COVID-19 vaccines specifically, which are essential to identify key solutions and action points to strengthen vaccine roll-out.
METHODS: We did an in-depth semi-structured qualitative interview study of recently arrived migrants (foreign-born, >18 years old; <10 years in the UK) to the UK with precarious immigration status between September 2020 and March 2021, seeking their input into strategies to strengthen COVID-19 vaccine delivery and uptake. We used the 'Three Cs' model (confidence, complacency and convenience) to explore COVID-19 vaccine hesitancy, barriers and access. Data were analysed using a thematic framework approach. Data collection continued until data saturation was reached, and no novel concepts were arising. The study was approved by the University of London ethics committee (REC 2020.00630).
RESULTS: We approached 20 migrant support groups nationwide, recruiting 32 migrants (mean age 37.1 years; 21 [66%] female; mean time in the UK 5.6 years [SD 3.7 years]), including refugees (n = 3), asylum seekers (n = 19), undocumented migrants (n = 8) and migrants with limited leave to remain (n = 2) from 15 different countries (5 WHO regions). 23 (72%) of 32 migrants reported being hesitant about accepting a COVID-19 vaccine and two (6%) would definitely not accept a vaccine. Participants communicated concerns over vaccine content, side-effects, lack of accessible information in an appropriate language, lack of trust in the health system and low perceived need. A range of barriers to accessing the COVID-19 vaccine were reported and concerns expressed that their communities would be excluded from or de-prioritised in the roll-out. Undocumented migrants described fears over being charged and facing immigration checks if they present for a vaccine. Participants (n = 10) interviewed after recent government announcements that COVID-19 vaccines can be accessed without facing immigration checks remained unaware of this. Participants stated that convenience of access would be a key factor in their decision around whether to accept a vaccine and proposed alternative access points to primary care services (for example, walk-in centres in trusted places such as foodbanks, community centres and charities), alongside promoting registration with primary care for all, and working closely with communities to produce accessible information on COVID-19 vaccination.
CONCLUSIONS: Precarious migrants may be hesitant about accepting a COVID-19 vaccine and face multiple and unique barriers to access, requiring simple but innovative solutions to ensure equitable access and uptake. Vaccine hesitancy and low awareness around entitlement and relevant access points could be easily addressed with clear, accessible, and tailored information campaigns, co-produced and delivered by trusted sources within marginalised migrant communities. These findings have immediate relevance to the COVID-19 vaccination initiatives in the UK and in other European and high-income countries with diverse migrant populations. FUNDING: NIHR.
© 2021 The Author(s).

Entities:  

Year:  2021        PMID: 34075367      PMCID: PMC8154190          DOI: 10.1016/j.jmh.2021.100050

Source DB:  PubMed          Journal:  J Migr Health        ISSN: 2666-6235


  21 in total

1.  Immunisation status of UK-bound refugees between January, 2018, and October, 2019: a retrospective, population-based cross-sectional study.

Authors:  Anna Deal; Sally E Hayward; Alison F Crawshaw; Lucy P Goldsmith; Charles Hui; Warren Dalal; Fatima Wurie; Mary-Ann Bautista; May Antonnette Lebanan; Sweetmavourneen Agan; Farah Amin Hassan; Kolitha Wickramage; Ines Campos-Matos; Sally Hargreaves
Journal:  Lancet Public Health       Date:  2022-05-28

Review 2.  Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.

Authors:  Alison F Crawshaw; Yasmin Farah; Anna Deal; Kieran Rustage; Sally E Hayward; Jessica Carter; Felicity Knights; Lucy P Goldsmith; Ines Campos-Matos; Fatima Wurie; Azeem Majeed; Helen Bedford; Alice S Forster; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2022-04-13       Impact factor: 71.421

3.  SARS-CoV-2 attack rate in reception and accommodation centres for asylum seekers during the first wave: Systematic review of outbreak media reports in Germany.

Authors:  Rosa Jahn; Maren Hintermeier; Kayvan Bozorgmehr
Journal:  J Migr Health       Date:  2022-02-04

Review 4.  Ethnic/racial minorities' and migrants' access to COVID-19 vaccines: A systematic review of barriers and facilitators.

Authors:  Mohammed Abba-Aji; David Stuckler; Sandro Galea; Martin McKee
Journal:  J Migr Health       Date:  2022-02-18

5.  Vulnerable migrants' access to healthcare in the early stages of the COVID-19 pandemic in the UK.

Authors:  L Fu; A Lindenmeyer; J Phillimore; L Lessard-Phillips
Journal:  Public Health       Date:  2021-12-15       Impact factor: 2.427

6.  COVID-19 vaccine hesitancy among undocumented migrants during the early phase of the vaccination campaign: a multicentric cross-sectional study.

Authors:  Kathleen R Page; Eleonora Genovese; Matteo Franchi; Silvano Cella; Gianfrancesco Fiorini; Rim Tlili; Sebastian Salazar; Aline Duvoisin; Johann Cailhol; Yves Jackson
Journal:  BMJ Open       Date:  2022-03-17       Impact factor: 2.692

7.  Vaccination against COVID-19: Factors That Influence Vaccine Hesitancy among an Ethnically Diverse Community in the UK.

Authors:  Erica Jane Cook; Elizabeth Elliott; Alfredo Gaitan; Ifunanya Nduka; Sally Cartwright; Chimeme Egbutah; Gurch Randhawa; Muhammad Waqar; Nasreen Ali
Journal:  Vaccines (Basel)       Date:  2022-01-11

8.  A Multilingual App for Providing Information to SARS-CoV-2 Vaccination Candidates with Limited Language Proficiency: Development and Pilot.

Authors:  Eva Maria Noack; Jennifer Schäning; Frank Müller
Journal:  Vaccines (Basel)       Date:  2022-02-25

Review 9.  The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review.

Authors:  Eleonore Batteux; Freya Mills; Leah Ffion Jones; Charles Symons; Dale Weston
Journal:  Vaccines (Basel)       Date:  2022-03-03

10.  COVID-19 vaccine hesitancy in people with migratory backgrounds: a cross-sectional study among Turkish- and German-speaking citizens in Munich.

Authors:  Zekeriya Aktürk; Klaus Linde; Alexander Hapfelmeier; Raphael Kunisch; Antonius Schneider
Journal:  BMC Infect Dis       Date:  2021-12-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.